University Hospitals Birmingham NHS Foundation Trust

Reports

Status Drug name NICE TAs Comments
Status: Green Cyclizine injection

For palliative care use
Status: Amber Cyclopentolate 0.5% and 1% single dose eye drops

Specialist ophthalmologist recommendation. Use by glaucoma surgeons for neovascular glaucoma.
Status: Amber Cyclopentolate hydrochloride 0.5% and 1% single dose

Specialist ophthalmologist recommendation
Status: Red Cyclophosphamide injection

For hospital use only
Status: Red Cyclophosphamide tablets

For oncology
Status: Red Cyclophosphomide

Neurology indication
Status: Red Cytarabine injection

Funding approval should be sought before initiation
Status: Red Cytarabine liposomal injection

For hospital use only
Status: Amber Dabigatran capsules

Following diagnosis of AF – use in line NICE and toolkit, initiation/recommendation by haematologist, transfer to GP with RICaD. For the treatment and secondary prevention of DVT and/or PE - use in line with NICE. Initiation/recommendation by haematologist, transfer to GP with RICaD

Adults only
Status: Red Dabigatran capsules #2.8

Use following hip and knee surgery – full course of treatment supplied on discharge
Building healthier lives
Back to top